How academic medical centers and health systems are rising to meet the challenge of innovation
Technology and InnovationTransformation InnovationHealthcareBoard and CEO AdvisoryBoard EffectivenessExecutive Search
Article Icon Report
April 09, 2018
3 min read
Technology and InnovationTransformation InnovationHealthcareBoard and CEO AdvisoryBoard EffectivenessExecutive Search
rra-image-asset-102.jpg

Adapted from a joint study by Duke University School of Medicine, Harvard Business School and Russell Reynolds Associates, published in Healthcare Management Policy and Innovation.

how-med-center-infographic-rising-pic1.jpg
how-med-center-infographic-rising-pic2.jpg
how-med-center-infographic-rising-pic3.jpg
how-med-center-infographic-rising-pic4.jpg
how-med-center-infographic-rising-pic5.jpg
how-med-center-infographic-rising-pic6.jpg
how-med-center-infographic-rising-pic7.jpg
how-med-center-infographic-rising-pic8.jpg

AUTHORS 

KATE HARVEY is a member of the Russell Reynolds Associates’ Healthcare Services Practice. Her executive search and assessment work focuses on directors, deans, chairs, and chiefs for prominent medical schools, academic medical centers and cancer centers, as well as chief executive officers, senior executive management, physician executive leadership and functional leadership positions. Her consulting experience is focused on the intersection of healthcare services innovation within prominent academic medical centers, integrated delivery networks, and private equity portfolio companies. Kate also serves as the health care lead for the Diversity and Inclusion practice. She is based in New York.
277 Park Avenue | Suite 3800
New York | NY 10172
United States
Phone: +1-212-351-2061
kate.harvey@russellreynolds.com

JOY LEE is a member of the Russell Reynolds Associates’ Healthcare Services Practice and a member of the Diversity and Inclusion Practice. She supports the North American Healthcare team by executing data-driven research and market intelligence efforts, generating industry insights, and providing operational support. Her work spans academic medical centers, health systems, payers, Fortune 500, and PE/VC-backed clients. She is based in New York.

LAUREN MCCOURT is a member of the Russell Reynolds Associates’ Healthcare sector and a founding member of the Digital Health Transformation Practice. She supports the North American Healthcare team by developing, planning and executing business development projects and strategic initiatives for the region. Her work focuses on biotechnology, pharmaceutical, diagnostics, digital health, healthcare IT and PE/VC-backed clients. She is based in Chicago.

AMY SADDINGTON is a member of Russell Reynolds Associates’ Healthcare Services Practice, and Co-Leads the Digital Health Transformation Practice. She helps companies build excellent leadership teams given the changing healthcare industry dynamics, and she advises clients on leadership topics and succession planning strategies. Her clients include private equity firms, Fortune 500, health systems, payors, digital and healthcare IT companies. Amy’s recent work includes CEO searches for private equity-backed digitally enabled healthcare companies, President and COO searches for healthcare IT companies, and Chief Innovation Officer roles within large academic medical centers. She is based in Dallas.
200 Crescent Court | Suite 1000
Dallas | TX 75201-1834
United States
Phone: +1-469-232-3539
amy.saddington@russellreynolds.com

KEVIN A. SCHULMAN, MD, MBA, serves as a professor of medicine at Duke University where he is the Founding Director of the unique Master of Management in Clinical Informatics program (MMCi). He also currently serves as a Visiting Scholar at Harvard Business School. Dr. Schulman’s research interests include organizational innovation in health care, health care policy and health economics.

SNEHA SHAH, MBA, is currently a fourth year medical student at the Johns Hopkins School of Medicine. She completed her MBA at Harvard Business School last year. She previously worked in corporate strategy at Moderna Therapeutics, where she partnered with venture presidents and the executive leadership to prioritize projects and build the 2016 long range plan, a strategy presented annually to the Board of Directors.